Adage Capital Partners Gp, L.L.C. Abeona Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,249,994 shares of ABEO stock, worth $14.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,249,994
Previous 3,249,994
-0.0%
Holding current value
$14.7 Million
Previous $16.3 Million
44.71%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ABEO
# of Institutions
65Shares Held
14.4MCall Options Held
715KPut Options Held
58K-
Nantahala Capital Management, LLC New Canaan, CT2.31MShares$10.4 Million1.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.99MShares$8.96 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA1.36MShares$6.14 Million4.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$4.97 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX889KShares$4.01 Million0.85% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $26.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...